MAP2K7 and leukemia: The BCR-ABL oncoprotein is a key molecular basis for leukemia pathogenesis, playing important roles in cell proliferation, survival, and immunosuppression through the activation of several downstream signalling pathways, such as the JAK/STAT, PI3K/AKT, and Raf/MEK/ERK pathways57.